Creekside Partners’s AbbVie ABBV Stock Holding History

Creekside Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$420K	Sell	1,930 -27	-1%	-$5.99K	0.17%	115
2025 Q4	$447K	Hold	1,957	–	–	0.19%	110
2025 Q3	$453K	Hold	1,957	–	–	0.2%	108
2025 Q2	$363K	Hold	1,957	–	–	0.17%	123
2025 Q1	$410K	Hold	1,957	–	–	0.21%	103
2024 Q4	$348K	Hold	1,957	–	–	0.18%	123
2024 Q3	$386K	Hold	1,957	–	–	0.2%	116
2024 Q2	$336K	Buy	+1,957	New	+$324K	0.19%	123

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Creekside Partners's ABBV Position: Q1 2026 in Review

Creekside Partners reduced its AbbVie (ABBV) stake by 1.4% in Q1 2026, selling an estimated $5.99K and leaving 1,930 shares worth $420K. The position accounts for 0.17% of the portfolio, ranked #115.

Creekside Partners first reported a position in ABBV in Q2 2024 and has held it in 8 quarters since. The position peaked at $453K in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Creekside Partners held 1,930 shares of AbbVie worth $420K as of Q1 2026.
Creekside Partners sold 27 AbbVie shares in Q1 2026, an estimated $5.99K.
AbbVie made up 0.17% of Creekside Partners's portfolio in Q1 2026, its #115 holding.
Creekside Partners first reported a position in AbbVie in Q2 2024 and has held it in 8 quarters since.
Creekside Partners's AbbVie position peaked at $453K in Q3 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Creekside Partners's 13F filing for Q1 2026, filed 22 Apr 2026.